RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Background: Traditional Chinese medicine (TCM) syndromes (ZHENG in Chinese) constitute the basis of understanding the disorders of patients and guiding the use of the Chinese herbs. Colorectal cancer is divided into various subtypes mainly according to the ZHENG identification.
Objective: We aimed to determine the molecular basis underlying Pi-Xu (spleen deficiency) and Shi-Re (dampness-heat) ZHENG that are commonly found in colorectal cancer patients.
Methods: About 80 colorectal cancer patients, including 47 Pi-Xu ZHENG and 33 Shi-Re ZHENG were enrolled. Blood and tissue samples of these patients were available for protein and mRNA expression. The protein expression was determined by Immunohistochemistry (IHC) staining and mRNA profiling was detected by expression microarray. Furthermore, mRNA fold change was evaluated by qRT-PCR.
Results: The colorectal cancer patients with Shi-Re ZHENG had a poor prognosis, compared with Pi-Xu ZHENG (95% CI: 0.05–0.33; p < 0.0001). Moreover, there was a significant difference in protein expression levels (especially for mutant TP53, PCNA, PD-L1 and Ki-67) among Pi-Xu and Shi-Re ZHENG (p < 0.01). Meanwhile, mRNA expression (especially for wild type TP53, KDM6A, PCNA, PD-L1, Ki-67, CCL-2, IL-1a and COX-2) was also remarkably different between Pi-Xu and Shi-Re groups (p < 0.01).
Conclusion: Our results suggest that Shi-Re ZHENG conditions may contribute to poor overall survival in patients with colorectal cancer. Compared with Pi-Xu ZHENG, high expression of mutant TP53, PCNA, PD-L1, Ki-67, CCL-2, IL-1a and COX-2 may serve as potential biomarkers for diagnosis and prognosis of colorectal cancer patients displayed Shi-Re ZHENG.

참고문헌 (Reference)

1 Du P, "lumi: a pipeline for processing Illumina microarray" 24 : 1547-1548, 2008

2 Lv AP, "Zheng classification in Chinese medicine: from its integration with disease diagnosis to clinical effectiveness assessment and combinational new drug discovery" 35 : 942-945, 2015

3 Kim JH, "UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells" 74 : 1705-1717, 2014

4 Liu Z, "Traditional Chinese medicine syndrome-related herbal prescriptions in treatment of malignant tumors" 33 : 19-26, 2013

5 Ling CQ, "Three advantages of using traditional Chinese medicine to prevent and treat tumor" 12 : 331-335, 2014

6 Cheng CW, "The quintessence of traditional Chinese medicine: syndrome and its distribution among advanced cancer patients with constipation" 2012 : 2012

7 Sui X, "The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PDL1 antibodies in cancer patients" 6 : 19393-19404, 2015

8 van der Stok EP, "Surveillance after curative treatment for colorectal cancer" 14 : 297-315, 2017

9 Ji Q, "Research advances in traditional Chinese medicine syndromes in cancer patients" 14 : 12-21, 2016

10 Parker HS, "Preserving biological heterogeneity with a permuted surrogate variable analysis for genomics batch correction" 30 : 2757-2763, 2014